Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases

Thrombosis Research

Volumn 128, Issue 2, 2011, Pages 186-190

  Kawasugi, Kazuo ^a   Wada, Hideo ^b   Hatada, Tsuyoshi ^c   Okamoto, Kohji ^d   Uchiyama, Toshimasa ^e   Kushimoto, Shigeki ^f   Seki, Yoshinobu ^g   Okamura, Takashi ^h   Nobori, Tsutomu ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b MIE UNIVERSITY   (Japan)

^c MIE UNIVERSITY HOSPITAL   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION TAKASAKI GENERAL MEDICAL CENTER   (Japan)

^f NIPPON MEDICAL SCHOOL   (Japan)

^g Department of Internal Medicine   (Japan)

^h KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DIC; Global coagulation test; Hemostatic molecular marker; Mortality; Underlying disease

Indexed keywords

ANTITHROMBIN; FIBRIN; FIBRINOGEN; PLASMIN INHIBITOR; THROMBOMODULIN;

ANEURYSM; ARTICLE; BURN; CARDIOVASCULAR DISEASE; COLLAGEN DISEASE; DISSEMINATED INTRAVASCULAR CLOTTING; GASTROINTESTINAL DISEASE; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION; INJURY; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; SOLID TUMOR; THROMBOCYTE COUNT;

AGED; AGED, 80 AND OVER; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 79960408858     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.02.015     Document Type: Article

References (26)

1. H. Wada Disseminated intravascular coagulation Clin Chim Acta 344 2004 13 21 (Pubitemid 38626133)
2. F.B. Taylor Jr., C.H. Toh, W.K. Hoots, H. Wada, and M. Levi Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - On behalf of the Scientific Subcommittee on disseminated intravascular coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH) Thromb Haemost 86 2001 1327 1330 (Pubitemid 33064585)
3. H. Wada, T. Nagano, M. Tomeoku, M. Kuto, Y. Karitani, K. Deguchi, and S. Shirakawa Coagulant and fibrinolytic activities in the leukemic cell lysates Thromb Res 30 1982 315 322 (Pubitemid 13053470)
4. H. Wada, Y. Kumeda, Z. Ogasawara, M. Ohiwa, T. Kaneko, S. Tamaki, T. Ohno, S. Kageyama, T. Kobayashi, K. Deguchi, and S. Shirakawa Plasminogen activators and their inhibitors in leukemic cell homogenates Am J Hematol 42 1993 166 170 (Pubitemid 23062168)
5. M.S. Tallman, S.A. Abutalib, and J.K. Altman The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia Semin Thromb Hemost 33 2007 330 338 (Pubitemid 46878105)
6. T. Iba, E. Nakarai, T. Takayama, K. Nakajima, T. Sasaoka, and Y. Ohno Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model Crit Care 13 2009 R203
7. T. Ito, K. Kawahara, T. Nakamura, S. Yamada, T. Nakamura, K. Abeyama, T. Hashiguchi, and I. Maruyama High-mobility group box 1 protein promotes development of microvascular thrombosis in rats J Thromb Haemost 5 2007 109 116 (Pubitemid 44921075)
8. M. Levi, E. de Jonge, and T. van der Poll Sepsis and disseminated intravascular coagulation J Thromb Thrombolysis 16 2003 43 47 (Pubitemid 38477222)
9. H. Wada, H. Asakura, K. Okamoto, T. Iba, T. Uchiyama, K. Kawasugi, S. Koga, T. Mayumi, K. Koike, S. Gando, S. Kushimoto, Y. Seki, S. Madoiwa, I. Maruyama, and A. Yoshioka Japanese Society of Thrombosis Hemostasis/DIC subcommittee: Expert consensus for the treatment of disseminated intravascular coagulation in Japan Thromb Res 125 2010 6 11
10. N. Kobayashi, T. Maegawa, M. Takada, H. Tanaka, and H. Gonmori Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan Bibl Haemotol 49 1983 265 275 (Pubitemid 14202230)
11. S. Gando, T. Kameue, S. Nanzaki, and Y. Nakanishi Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome Thromb Haemost 75 1996 224 228 (Pubitemid 26081471)
12. H. Wada, M. Yamamuro, A. Inoue, H. Shiku, N. Sakuragawa, H. Redl, G. Peer, and F.B. Tayler Jr. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. coli sepsis - Toward a distinct between uncompensated overt DIC and compensated non-overt DIC Thromb Haemost 86 2001 1489 1494 (Pubitemid 34007523)
13. H. Asakura, Y. Ontachi, T. Mizutani, M. Kato, T. Ito, M. Saito, E. Morishita, M. Yamazaki, K. Aoshima, A. Takami, T. Yoshida, Y. Suga, K. Miyamoto, and S. Nakao Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation Eur J Haematol 67 2001 170 175 (Pubitemid 33105057)
14. B.L. Warren, A. Eid, P. Singer, S.S. Pillay, P. Carl, I. Novak, P. Chalupa, A. Atherstone, I. Pěnzes, A. Kübler, S. Knaub, H.O. Keinecke, H. Heinrichs, F. Schindel, M. Juers, R.C. Bone, and S.M. Opal the KyberSept Trial Study Group: High-dose antithrombin in severe sepsis. A randomized controlled trial JAMA 286 2001 1869 1878 (Pubitemid 33010239)
15. G.R. Bernard, J.L. Vincent, P.F. Laterre, S.P. Larosa, J.F. Dhainaut, A. Lopez-Rodriguez, J.S. Steingrub, G.E. Garber, J.D. Helterbrand, W. Ely, and C.J. Fisher Efficacy and safety of recombinant human protein C for severe sepsis N Engl J Med 8 2001 699 709 (Pubitemid 32204987)
16. E. Abraham, K. Reinhart, S. Opal, I. Demeyer, C. Doig, A.L. Rodriguez, R. Beale, P. Svodoba, P.F. Laterre, S. Simons, B. Light, H. Spanen, J. Stone, A. Seibert, C. Peckelsen, C. De Deyne, R. Postier, V. Pettila, A. Artigas, S.R. Percell, V. Shu, C. Zwingelstein, J. Tobias, L. Poole, J.C. Stolzenbach, and A.A. Creasey Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial JAMA 290 2003 238 247 (Pubitemid 37430063)
17. H. Saito, I. Maruyama, S. Shimazaki, Y. Yamamoto, N. Aikawa, R. Ohno, A. Hirayama, T. Matsuda, H. Asakura, M. Nakashima, and N. Aoki Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial J Thromb Haemost 5 2007 31 41 (Pubitemid 44921064)
18. M. Levi, C.H. Toh, J. Thachil, and H.G. Watson Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology Br J Haematol 145 2009 24 33
19. H. Wada, T. Hatada, K. Okamoto, T. Uchiyama, K. Kawasugi, T. Mayumi, S. Gando, S. Kushimoto, Y. Seki, S. Madoiwa, and T. Okamura Japanese Society of Thrombosis Hemostasis/DIC subcommittee.: Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC Am J Hematol 85 2010 691 694
20. G.T. Kinasewitz, J.G. Zein, G.L. Lee, S.A. Nazir, and F.B. Taylor Jr. Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis Crit Care Med 33 2005 2214 2221 (Pubitemid 41437473)
21. S. Gando, T. Iba, and Y. Eguchi Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria Crit Care Med 34 2006 625 631
22. H. Wada, E.C. Gabazza, T. Nakasaki, M. Shimura, K. Hiyoyama, K. Deguchi, M. Nishikawa, N. Sakuragawa, and H. Shiku Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers Semin Thromb Hemost 26 2000 17 22 (Pubitemid 30238012)
23. H. Wada, N. Sakuragawa, and H. Shiku Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients Semin Thromb Hemost 24 1998 293 297 (Pubitemid 28345741)
24. S. Gando, M. Hayakawa, A. Sawamura, H. Hoshino, A. Oshiro, N. Kubota, and S. Jesmin The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation Thromb Res 121 2007 67 73 (Pubitemid 350027772)
25. H. Wada, Y. Mori, M. Shimura, K. Hiyoyama, T. Nakasaki, M. Ioka, M. Nakano, M. Nishikawa, K. Kumeda, S. Nakamura, and H. Shiku Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries Am J Heamtol 58 1998 189 194 (Pubitemid 28303546)
26. T. Hatada, H. Wada, T. Nobori, K. Okabayashi, K. Maruyama, Y. Abe, S. Uemoto, S. Yamada, and I. Maruyama Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation Thromb Haemost 94 2005 975 979 (Pubitemid 41645937)